RAMP · LiveRamp Holdings, Inc. · Stock research

Current Thesis

The shareholder gate is closed. 92.23% of the 60,786,315 outstanding at the 2026-06-18 record date (Form 8-K, Item 5.07, filed 2026-08-17). Against a 66⅔%-of-outstanding threshold, the affirmative count cleared the bar with room; the adjournment proposal was not even submitted. What remains between here and $38.50 in cash from MMS USA Holdings, Inc., a Publicis Groupe subsidiary, is entirely regulatory: HSR expiration or termination (notifications filed 2026-06-11), CFIUS approval, and non-US antitrust and foreign-direct-investment clearances. None of the three has been publicly confirmed. The observable that changed with the vote is not the one a spread trader would expect: the 2026-08-21 close of $37.58 sits $0.92 under the contract price, wider than the $0.65 gap at the 2026-08-14 close of $37.85. Four sessions after the last equity-holder condition was removed, the discount grew instead of compressing.

Bullish and bearish views on LiveRamp Holdings, Inc.

The model's bull view on LiveRamp Holdings, Inc. (RAMP), in brief: The largest discrete condition is retired. The bear view: The spread widened through the catalyst. Both cases follow in full.

Bull Case

• The largest discrete condition is retired. 51,578,202 votes for versus 60,073 against on 2026-08-17 — an approval ratio that leaves no ambiguity about register support, and no adjournment was needed to reach it (Form 8-K, 2026-08-17).
• The price is set by contract, not by a multiple. $38.50 per share in cash, agreement dated 2026-05-16, unanimous board approval, no financing condition, ~$2.5B equity value, ~30% premium to the 2026-05-15 close of $29.66.
• Turnout signals a concentrated, deal-aware register. 92.23% of outstanding shares were represented; only 4,374,869 broker non-votes accumulated against a threshold that treats unvoted street-name shares as no votes. The mechanical vote risk flagged before the meeting did not bind.
• Schedule discipline has held at every dated step. HSR filings 2026-06-11, record date 2026-06-18, DEFM14A definitive 2026-07-06, meeting held on the calendared date 2026-08-17, Item 5.07 filed same day.
• Timing slack beyond the target. Reciprocal termination fee of $32.35M; targeted close 2026-12-31; outside date 2027-05-16, extendable three months for regulatory reasons.
• A break lands on a profitable standalone. FY2026 (ended 2026-03-31): revenue $812.9M, +9% YoY; net earnings $146.0M; operating cash flow $167.8M; ~$379M net cash. Q1 FY2027, reported 2026-08-05: revenue $213.986M against $211.447M consensus, adjusted EPS $0.65 against $0.58.

Bear Case

• The spread widened through the catalyst. $0.65 under the cash price at the 2026-08-14 close; $0.92 under at the 2026-08-21 close. A vote that removes a condition and is followed by a wider discount is the market repricing either the probability or the duration of the remaining regulatory path. Which of the two is an inference, not a measurement — no clearance filing has been published either way.
• Three unconfirmed conditions, no scheduled date for any of them. Trade coverage dated 2026-07-23 listed HSR, CFIUS and non-US antitrust/FDI as all pending, and nothing published since the vote has confirmed a single clearance.
• CFIUS is the live variable. A French acquirer taking a US identity graph and consumer-data asset is the fact pattern that draws a national-security review; the outcome could be clearance, a mitigation agreement, an extension, or a block, and only the first is priced.
• Asymmetry is unchanged by the vote. From $37.58 the move up to $38.50 is roughly 2.4% gross; the move back to the 2026-05-15 pre-announcement close of $29.66 is roughly -21%. The 30% premium was paid on 2026-05-17 to whoever owned it the day before.
• The advisory compensation vote failed badly — 7,304,002 for against 44,262,875 opposed on the merger-related pay proposal. Non-binding, and it does not touch the closing conditions, but it puts on the record that a large majority of voted shares rejected the retention and severance economics disclosed in the 2026-07-06 proxy and its supplements.
• Time decay is the quiet cost. A ~2.4% gross spread earned to 2026-12-31 is one annualized figure; the same spread earned to a 2027 close is a materially worse one, with the downside to $29.66 unchanged throughout.

Setup & Price Structure

The chart is not a chart of a business. The 2026-08-21 close of $37.58 sits -1.1% below the 52-week high of $38.01 — a high that is itself below the $38.50 contract price, meaning the stock has never traded to the deal cap since announcement. The three-month price change is -0.3%, and RSI(14) reads 37.6: a momentum oscillator drifting toward oversold on a price that has barely moved, which is what mean-reversion math does to a pinned quote. Moving averages, breakout shelves and trend structure carry no information while a signed all-cash agreement bounds the range.

The operative structure is a band. The ceiling is $38.50 minus the market's discount for time and regulatory risk. The floor is not technical — it is the market's estimate of standalone value, anchored by the 2026-05-15 close of $29.66, which sits roughly 21% below the current quote. Between them the price does one thing: it encodes completion odds. The move from $37.85 (2026-08-14) to $37.58 (2026-08-21) across the vote is that encoding shifting the wrong way for the deal.

The narrative is maturing. The name is well known to the event-driven audience — 92.23% meeting turnout on 2026-08-17 is direct evidence of that — and the trade still functions, but the headline flow has moderated to procedural filings and the remaining path has no dated news. It is not accelerating: the last fresh catalyst was the vote, and it is behind. It is not saturated in the retail sense; there is no crowded momentum bid to exhaust, and no evidence of retail-sentiment clustering has surfaced. It is not dead: the agreement stands, the vote passed, and the price remains within a dollar of the cash consideration.

4,374,869 broker non-votes; No earnings date sits inside 30 days — Q2 FY2027 would fall around early November 2026 and only matters if the deal has not closed. No insider transaction data is cited here because none has been verified for the post-vote window.

Catalyst Calendar (next 30 days)

• No scheduled dated event falls between 2026-08-23 and 2026-09-22. The vote (2026-08-17) and its Item 5.07 filing (2026-08-17) are done; the next fixed date on the calendar is the targeted close.
• Undated, any day: CFIUS determination or extension. The single condition with the widest outcome distribution and no public timetable.
• ~2026-11-04 (est.): Q2 FY2027 results, relevant only in the scenario where the merger has not closed.
• 2026-12-31: targeted closing date stated by the parties. Passing it without clearances does not break the deal, but it moves the return calculation into 2027.
• 2027-05-16: outside date, extendable three months for regulatory reasons.

Elapsed catalysts

• Undated, any day: HSR expiration or termination. Notifications were filed 2026-06-11. Confirmation would arrive via 8-K or a party press release; a DOJ or FTC second request would arrive the same way. (passed 76d ago)

What Would Change Our Mind

The structure that breaks first is the arb band, and it breaks on regulatory news, not on tape. A disclosed CFIUS extended review, a national-security mitigation agreement, a DOJ or FTC second request, or either party invoking the three-month extension past 2027-05-16 would each convert this from spread convergence into a broken special situation with $29.66 as the reference point the market last paid for the standalone company. On price, a daily close below $35 is the gradeable line: at that level the discount to $38.50 has widened past anything explicable by carry and time, and the market is pricing meaningful completion risk. The mirror condition also matters — if HSR and CFIUS clearances are confirmed and the spread does not compress toward the cash price, the widening is telling a story the filings are not.

A second way to be wrong: the 2026-12-31 target close comes and goes with no clearance announcement and no revised guidance from either party. That does not break the agreement, but a spread earned over eighteen months instead of four and a half months is a different instrument from the one described here.

Correlation Notes

• Index beta is suppressed by construction. While the agreement stands, S&P and Nasdaq moves reach this price only through break-value expectations. The evidence is in the flatness: a three-month price change of -0.3% with the stock within 1.1% of its 52-week high.
• The acquirer is the relevant equity cross-reference. Publicis Groupe (PUB.PA) carries no financing condition here, so its share price does not mechanically alter the consideration; a strategic reversal or a balance-sheet event at Publicis would show up as deal risk, not as a valuation link.
• Peer adtech and identity names matter only in the break case. The Trade Desk and Criteo set the comparable multiples RAMP would re-rate against if the merger terminates; while the cap holds, their moves have no transmission channel into this price.
• The correlated basket is other CFIUS-exposed, foreign-acquirer deals. Washington policy headlines on foreign ownership of US consumer-data assets move that complex together, and this spread sits squarely inside it.
• RSI(14) at 37.6 alongside a price 1.1% off the 52-week high is an artifact of a flat quote, not distribution or accumulation; technical signals on a contract-capped stub should be read as noise.